Clinical Trials Browser

Phase 3 × Kidney Neoplasms × Interleukin-2 × Clear all

NCT00003126 2017-01-04

Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer

Phase 3 Completed

Carcinoma, Renal Cell, Kidney Neoplasms